Fangyi Zhao

3.7k total citations · 1 hit paper
57 papers, 2.4k citations indexed

About

Fangyi Zhao is a scholar working on Psychiatry and Mental health, Immunology and Physiology. According to data from OpenAlex, Fangyi Zhao has authored 57 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 12 papers in Immunology and 9 papers in Physiology. Recurrent topics in Fangyi Zhao's work include Schizophrenia research and treatment (14 papers), Psoriasis: Treatment and Pathogenesis (10 papers) and Spondyloarthritis Studies and Treatments (7 papers). Fangyi Zhao is often cited by papers focused on Schizophrenia research and treatment (14 papers), Psoriasis: Treatment and Pathogenesis (10 papers) and Spondyloarthritis Studies and Treatments (7 papers). Fangyi Zhao collaborates with scholars based in United States, China and Japan. Fangyi Zhao's co-authors include Charles F. Louis, Bradley R. Fruen, S. R. Wayne Chen, Pin Li, Lotus Mallbris, Ranji Cui, Gregory S. Cameron, Holland C. Detke, Kim Papp and Daniel Braun and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Blood.

In The Last Decade

Fangyi Zhao

54 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

2016 650 citations Kim Papp, Mamitaro Ohtsuki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fangyi Zhao United States	24	978	484	449	428	398	57	2.4k
Joana Gonçalves Portugal	25	591 0.6×	347 0.7×	388 0.9×	117 0.3×	112 0.3×	56	1.8k
Kerstin Sander Germany	30	548 0.6×	191 0.4×	644 1.4×	255 0.6×	118 0.3×	70	2.9k
Fabrizio Giuliani Canada	29	1.2k 1.3×	90 0.2×	1.1k 2.5×	214 0.5×	364 0.9×	69	4.6k
Giovanna Di Trapani Italy	24	374 0.4×	82 0.2×	853 1.9×	355 0.8×	81 0.2×	89	2.3k
Dong Zhou China	44	370 0.4×	56 0.1×	2.2k 4.8×	531 1.2×	120 0.3×	107	5.5k
Johannes C. Huber Austria	33	310 0.3×	103 0.2×	295 0.7×	201 0.5×	83 0.2×	99	2.9k
Sang Eun Kim South Korea	28	148 0.2×	204 0.4×	660 1.5×	156 0.4×	115 0.3×	134	2.7k
Koji Masuda Japan	21	194 0.2×	435 0.9×	462 1.0×	41 0.1×	150 0.4×	96	1.7k
Øivind Torkildsen Norway	31	797 0.8×	32 0.1×	714 1.6×	214 0.5×	322 0.8×	126	3.3k
Frederik J. Steyn Australia	33	373 0.4×	34 0.1×	814 1.8×	114 0.3×	160 0.4×	96	3.7k

Countries citing papers authored by Fangyi Zhao

Since Specialization

Citations

This map shows the geographic impact of Fangyi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyi Zhao more than expected).

Fields of papers citing papers by Fangyi Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyi Zhao. The network helps show where Fangyi Zhao may publish in the future.

Co-authorship network of co-authors of Fangyi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyi Zhao. A scholar is included among the top collaborators of Fangyi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyi Zhao. Fangyi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Hanpeng, et al.. (2025). Bioinspired multifunctional antifogging surfaces: Progress, AI design and challenges. Progress in Materials Science. 155. 101530–101530. 1 indexed citations

Zhao, Fangyi, et al.. (2024). Role of estrogen in treatment of female depression. Aging. 16(3). 3021–3042. 18 indexed citations

Au, Man Ting, Kaiming Tang, Wei Wang, et al.. (2024). Blockade of endothelin receptors mitigates SARS-CoV-2-induced osteoarthritis. Nature Microbiology. 9(10). 2538–2552. 2 indexed citations

Gao, Hanpeng, Fangyi Zhao, Jiaxi Liu, et al.. (2024). What Exactly Can Bionic Strategies Achieve for Flexible Sensors?. ACS Applied Materials & Interfaces. 16(30). 38811–38831. 7 indexed citations

Cheng, Ziqian, et al.. (2024). Rasd2 regulates depression-like behaviors via DRD2 neurons in the prelimbic cortex afferent to nucleus accumbens core circuit. Molecular Psychiatry. 30(2). 435–449. 5 indexed citations

Zhao, Fangyi, et al.. (2024). Traditional Chinese herbal formula, Fuzi-Lizhong pill, produces antidepressant-like effects in chronic restraint stress mice through systemic pharmacology. Journal of Ethnopharmacology. 338(Pt 1). 119011–119011. 1 indexed citations

Cui, Ranji, et al.. (2023). Fasting produces antidepressant-like effects via activating mammalian target of rapamycin complex 1 signaling pathway in ovariectomized mice. Neural Regeneration Research. 0(0). 0–0. 5 indexed citations

Wang, Yicun, et al.. (2023). Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines. Aging. 15(12). 5917–5950. 46 indexed citations

Gold, Linda Stein, Diamant Thaçi, Jacob P. Thyssen, et al.. (2023). Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials. American Journal of Clinical Dermatology. 24(4). 595–607. 34 indexed citations

10.

Zhao, Fangyi, Kai Zhang, Hongyu Chen, et al.. (2023). Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19. Inflammopharmacology. 32(1). 229–247. 4 indexed citations

11.

Dougados, Maxime, James Cheng‐Chung Wei, Robert Landewé, et al.. (2019). Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Annals of the Rheumatic Diseases. 79(2). 176–185. 86 indexed citations

12.

Mease, Philip J., Jessica A. Walsh, Xenofon Baraliakos, et al.. (2019). Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis. Rheumatology and Therapy. 6(3). 435–450. 17 indexed citations

13.

Egeberg, Alexander, Jashin J. Wu, Neil J. Korman, et al.. (2018). Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3. Journal of the American Academy of Dermatology. 79(1). 104–109.e8. 51 indexed citations

14.

Duffin, Kristina Callis, Jerry Bagel, Michael Bukhalo, et al.. (2016). Phase 3, open‐label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate‐to‐severe plaque psoriasis (UNCOVER‐A). Journal of the European Academy of Dermatology and Venereology. 31(1). 107–113. 35 indexed citations

15.

Papp, Kim, Robert Bissonnette, Mamitaro Ohtsuki, et al.. (2016). 059 Ixekizumab shows no association with MACE in patients with moderate-to-severe psoriasis: an integrated safety analysis of clinical trials. Journal of Investigative Dermatology. 136(9). S170–S170. 2 indexed citations

16.

Smolen, Josef S, Michael E. Weinblatt, Désirée van der Heijde, et al.. (2015). Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study. Annals of the Rheumatic Diseases. 74(8). 1567–1570. 27 indexed citations

17.

Zanarini, Mary C., S. Charles Schulz, Holland C. Detke, et al.. (2012). Open-Label Treatment With Olanzapine for Patients With Borderline Personality Disorder. Journal of Clinical Psychopharmacology. 32(3). 398–402. 11 indexed citations

18.

Fijal, Bonnie A., Virginia L. Stauffer, Bruce J. Kinon, et al.. (2011). Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone. The Journal of Clinical Psychiatry. 73(3). 367–371. 23 indexed citations

19.

Detke, Holland C., David McDonnell, Eric J. Brunner, et al.. (2010). Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases. BMC Psychiatry. 10(1). 43–43. 82 indexed citations

20.

Joseph, Anne M., Robin Bliss, Fangyi Zhao, & Harry A. Lando. (2005). Predictors of smoking reduction without formal intervention. Nicotine & Tobacco Research. 7(2). 277–282. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact